{"id":"https://openalex.org/W4404977533","doi":"https://doi.org/10.1017/s026646232400062x","title":"Results of health technology assessments of orphan drugs in Germany\u2014lack of added benefit, evidence gaps, and persisting unmet medical needs","display_name":"Results of health technology assessments of orphan drugs in Germany\u2014lack of added benefit, evidence gaps, and persisting unmet medical needs","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4404977533","doi":"https://doi.org/10.1017/s026646232400062x","pmid":"https://pubmed.ncbi.nlm.nih.gov/39623907","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11703625"},"language":"en","primary_location":{"id":"doi:10.1017/s026646232400062x","doi":"https://doi.org/10.1017/s026646232400062x","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s026646232400062x","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2576A23C63003BD36D9D0190831CB5B1/S026646232400062Xa.pdf/div-class-title-results-of-health-technology-assessments-of-orphan-drugs-in-germany-lack-of-added-benefit-evidence-gaps-and-persisting-unmet-medical-needs-div.pdf","source":{"id":"https://openalex.org/S83891556","display_name":"International Journal of Technology Assessment in Health Care","issn_l":"0266-4623","issn":["0266-4623","1471-6348"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","fnege-4","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Technology Assessment in Health Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2576A23C63003BD36D9D0190831CB5B1/S026646232400062Xa.pdf/div-class-title-results-of-health-technology-assessments-of-orphan-drugs-in-germany-lack-of-added-benefit-evidence-gaps-and-persisting-unmet-medical-needs-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091919914","display_name":"Philip Kranz","orcid":"https://orcid.org/0009-0002-7069-7504","observed_orcids":["https://orcid.org/0009-0002-7069-7504"]},"institutions":[{"id":"https://openalex.org/I3132465597","display_name":"Institute for Quality and Efficiency in Health Care","ror":"https://ror.org/02qz3vm75","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3132465597"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Philip Kranz","raw_affiliation_strings":["Researcher, Drug Assessment Department, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany"],"raw_orcid":"https://orcid.org/0009-0002-7069-7504","affiliations":[{"raw_affiliation_string":"Researcher, Drug Assessment Department, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany","institution_ids":["https://openalex.org/I3132465597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051399943","display_name":"Natalie McGauran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3132465597","display_name":"Institute for Quality and Efficiency in Health Care","ror":"https://ror.org/02qz3vm75","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3132465597"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Natalie McGauran","raw_affiliation_strings":["Researcher, Communications Department, IQWiG, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Researcher, Communications Department, IQWiG, Cologne, Germany","institution_ids":["https://openalex.org/I3132465597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078693302","display_name":"Can \u00dcnal","orcid":"https://orcid.org/0000-0003-4710-9567","observed_orcids":["https://orcid.org/0000-0003-4710-9567"]},"institutions":[{"id":"https://openalex.org/I3132465597","display_name":"Institute for Quality and Efficiency in Health Care","ror":"https://ror.org/02qz3vm75","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3132465597"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Can \u00dcnal","raw_affiliation_strings":["Researcher, Drug Assessment Department, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Researcher, Drug Assessment Department, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany","institution_ids":["https://openalex.org/I3132465597"]}]},{"author_position":"last","author":{"id":null,"display_name":"Thomas Kaiser","orcid":"https://orcid.org/0000-0003-0795-538X","observed_orcids":["https://orcid.org/0000-0003-0795-538X"]},"institutions":[{"id":"https://openalex.org/I3132465597","display_name":"Institute for Quality and Efficiency in Health Care","ror":"https://ror.org/02qz3vm75","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3132465597"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Kaiser","raw_affiliation_strings":["Director, IQWiG, Cologne, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0795-538X","affiliations":[{"raw_affiliation_string":"Director, IQWiG, Cologne, Germany","institution_ids":["https://openalex.org/I3132465597"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5091919914"],"corresponding_institution_ids":["https://openalex.org/I3132465597"],"apc_list":{"value":3450,"currency":"USD","value_usd":3450},"apc_paid":{"value":3450,"currency":"USD","value_usd":3450},"fwci":2.7756,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.90229031,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"40","issue":"1","first_page":"e68","last_page":"e68"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.5907999873161316,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.5907999873161316,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.39259999990463257,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.921999990940094},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.9739999771118164},{"id":"https://openalex.org/keywords/added-benefit","display_name":"added benefit","score":0.9679999947547913},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.8500000238418579},{"id":"https://openalex.org/keywords/evidence-gaps","display_name":"evidence gaps","score":0.8859999775886536},{"id":"https://openalex.org/keywords/patient-important-outcomes","display_name":"patient-relevant outcomes","score":0.7540000081062317},{"id":"https://openalex.org/keywords/germany","display_name":"Germany","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.7039387822151184},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6708860397338867},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.6525493860244751},{"id":"https://openalex.org/C21333345","wikidata":"https://www.wikidata.org/wiki/Q1519843","display_name":"Health technology","level":3,"score":0.6102212071418762},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.5601776838302612},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.5192280411720276},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.4644702970981598},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4291810095310211},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.1928350329399109},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.15502986311912537},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.1392064392566681},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000094505","descriptor_name":"Evidence Gaps","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005858","descriptor_name":"Germany","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013673","descriptor_name":"Technology Assessment, Biomedical","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1017/s026646232400062x","doi":"https://doi.org/10.1017/s026646232400062x","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s026646232400062x","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2576A23C63003BD36D9D0190831CB5B1/S026646232400062Xa.pdf/div-class-title-results-of-health-technology-assessments-of-orphan-drugs-in-germany-lack-of-added-benefit-evidence-gaps-and-persisting-unmet-medical-needs-div.pdf","source":{"id":"https://openalex.org/S83891556","display_name":"International Journal of Technology Assessment in Health Care","issn_l":"0266-4623","issn":["0266-4623","1471-6348"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","fnege-4","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Technology Assessment in Health Care","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11703625","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11703625","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11703625/pdf/S026646232400062Xa.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Technol Assess Health Care","raw_type":"Text"},{"id":"pmid:39623907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39623907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of technology assessment in health care","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1017/s026646232400062x","doi":"https://doi.org/10.1017/s026646232400062x","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s026646232400062x","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2576A23C63003BD36D9D0190831CB5B1/S026646232400062Xa.pdf/div-class-title-results-of-health-technology-assessments-of-orphan-drugs-in-germany-lack-of-added-benefit-evidence-gaps-and-persisting-unmet-medical-needs-div.pdf","source":{"id":"https://openalex.org/S83891556","display_name":"International Journal of Technology Assessment in Health Care","issn_l":"0266-4623","issn":["0266-4623","1471-6348"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","fnege-4","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Technology Assessment in Health Care","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404977533.pdf","grobid_xml":"https://content.openalex.org/works/W4404977533.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W1986376914","https://openalex.org/W2102951373","https://openalex.org/W2960772995","https://openalex.org/W3045930160","https://openalex.org/W4223493443","https://openalex.org/W4297005783","https://openalex.org/W4320497563","https://openalex.org/W4376118419","https://openalex.org/W4396692598"],"related_works":["https://openalex.org/W4311342885","https://openalex.org/W4405751882","https://openalex.org/W2130643721","https://openalex.org/W2899705083","https://openalex.org/W2766430698","https://openalex.org/W1904150290","https://openalex.org/W4311337624","https://openalex.org/W4311339061","https://openalex.org/W4412652359","https://openalex.org/W4405751781"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,99,178],"number":[2],"of":[3,33,101,107,191,200,208,221,230,237,249,268,273,305,317],"orphan":[4],"drug":[5],"(OD)":[6],"approvals":[7,62],"has":[8,63],"increased":[9],"sharply":[10],"in":[11,51,60,67,83,109,155,168,182,187,205,257,263,271,303],"Europe.":[12],"In":[13,195],"Germany,":[14],"all":[15],"ODs":[16,93,108,159,261,280],"are":[17,281,298],"initially":[18],"subject":[19],"to":[20,65,90,119,214,254,300,310],"a":[21,42],"limited":[22,102,183],"assessment":[23,46],"after":[24],"market":[25,77],"access.":[26],"Their":[27],"added":[28,122,179,201,269],"benefit":[29,123,129,180,202,270],"over":[30],"the":[31,58,73,88,139,192,209,219,231,264,315],"standard":[32,220,316],"care":[34],"is":[35,48],"accepted":[36],"as":[37,70],"established":[38,286],"upon":[39],"EU":[40,265],"approval;":[41],"regular":[43,105,163,175,196],"health":[44],"technology":[45],"(HTA)":[47],"performed":[49],"only":[50,246],"certain":[52],"cases.":[53],"OBJECTIVE:":[54],"We":[55,85],"assessed":[56],"whether":[57],"increase":[59],"OD":[61],"led":[64],"improvements":[66],"patient-relevant":[68,275],"outcomes":[69],"supported":[71],"by":[72,76],"evidence":[74,255],"submitted":[75],"authorization":[78],"holders":[79],"(MAHs)":[80],"for":[81,133,153,227,245,283],"HTA":[82,154],"Germany.":[84,156],"also":[86],"examined":[87],"extent":[89],"which":[91,238],"these":[92,243],"address":[94],"unmet":[95,293,306],"medical":[96,294,307],"needs.":[97],"METHODS:":[98],"results":[100],"assessments":[103,184],"and":[104,143,288,309],"HTAs":[106],"Germany":[110],"(January":[111],"2011-September":[112],"2021,":[113],"plus":[114],"January-December":[115],"2023)":[116],"were":[117,166,225],"analyzed":[118],"determine":[120],"their":[121],"based":[124],"on":[125],"MAH-submitted":[126],"dossiers.":[127],"Added":[128],"was":[130,185,203],"reported":[131],"separately":[132],"each":[134],"research":[135,170,302],"question":[136],"generated":[137],"from":[138],"EU-approved":[140],"therapeutic":[141],"indications":[142,241],"any":[144],"sub-indications":[145],"(e.g.,":[146],"different":[147],"subpopulations":[148],"or":[149],"control":[150],"interventions)":[151],"specified":[152],"RESULTS:":[157],"Eighty-nine":[158],"(limited":[160,172],"assessments:":[161,173],"sixty-nine;":[162],"HTAs:":[164,176],"twenty)":[165],"evaluated":[167],"175":[169],"questions":[171],"ninety-seven;":[174],"seventy-eight).":[177],"granted":[181],"non-quantifiable":[186],"nearly":[188],"eighty":[189],"percent":[190,207,229,248],"ninety-seven":[193],"questions.":[194],"HTAs,":[197],"no":[198],"proof":[199,267],"shown":[204],"fifty-four":[206],"seventy-eight":[210,232],"questions,":[211],"mainly":[212],"due":[213],"insufficient":[215],"comparative":[216,312],"data":[217,313],"with":[218,285,314],"care.":[222,318],"Established":[223],"treatments":[224,287],"available":[226],"fifty-eight":[228],"questions;":[233],"more":[234],"than":[235],"half":[236],"addressed":[239],"oncology":[240,289],"(although":[242],"account":[244],"eight":[247],"rare":[250],"diseases).":[251],"CONCLUSIONS:":[252],"Due":[253],"gaps":[256],"post-approval":[258],"HTA,":[259],"many":[260,292],"approved":[262,279],"lack":[266],"terms":[272],"improving":[274],"outcomes.":[276],"Moreover,":[277],"most":[278],"indicated":[282],"diseases":[284],"indications,":[290],"while":[291],"needs":[295],"remain.":[296],"Incentives":[297],"required":[299],"encourage":[301],"areas":[304],"need":[308],"generate":[311]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-12-04T00:00:00"}